ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Toronto, ON

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Nasal Polyps
Rhinitis
Rhinosinusitis
Sinusitis
Conjunctivitis

Asthma trials near Toronto, ON, CAN:

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (ARRIVAL)

administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...

Enrolling
Severe Asthma
Combination Product: Budesonide/formoterol
Combination Product: Mannitol

Phase 3

AstraZeneca
AstraZeneca

Ajax, Ontario, Canada and 83 other locations

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Burlington, Ontario, Canada and 83 other locations

This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...

Enrolling
Asthma
Asthma; Eosinophilic
Drug: Placebo
Drug: Dexpramipexole Dihydrochloride

Phase 3

Areteia Therapeutics

Ajax, Ontario, Canada and 331 other locations

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...

Enrolling
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

Phase 2

Upstream Bio

Toronto, Ontario, Canada and 147 other locations

study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...

Enrolling
Asthma
Other: Spirometry
Drug: Mepolizumab

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Toronto, Ontario, Canada and 65 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Ajax, Ontario, Canada and 314 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Burlington, Ontario, Canada and 122 other locations

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....

Enrolling
Asthma
Drug: Placebo
Drug: Rocatinlimab

Phase 2

Amgen
Amgen

Ajax, Ontario, Canada and 147 other locations

active should inform the impact of briquilimab on allergic asthma as compared to placebo while minimizing exposure to participants, in a new...

Enrolling
Allergic Asthma
Other: Placebo Comparator
Drug: Briquilimab

Phase 1

Jasper Therapeutics

Hamilton, Ontario, Canada and 5 other locations

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Enrolling
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

Phase 2

Incyte
Incyte

Ajax, Ontario, Canada and 84 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems